lululemon athletica inc. has 22 Schedule 13D or 13G filings on record since 2025-08-06. 4 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Dennis J. Wilson | 8.6% | 9,570,851 | SCHEDULE 13D/A, 2026-09-03 | 2026-09-01 |
| LIPO Investments (USA), Inc. | 8.4% | 3,401,596 | SCHEDULE 13D/A, 2025-12-15 | 2025-12-12 |
| Vanguard Capital Management | 7.22% | 7,985,349 | SCHEDULE 13G, 2026-04-28 | 2026-03-31 |
| G1 Execution Services, LLC | 5.7% | 6,487,961 | SCHEDULE 13G, 2025-11-13 | 2025-09-30 |
| Fmr LLC | 3.6% | 4,066,058 | SCHEDULE 13G/A, 2025-10-07 | 2025-09-30 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
Purpose of Transaction (Item 4)
LIPO Investments (USA), Inc.
Item 4 is hereby amended and supplemented as follows: On December 12, 2025, in response to the announcement of the market-unanticipated departure of the Issuer's Chief Executive Officer, Calvin McDonald, Mr. Wilson issued a press release (the "December 12th Press Release"), a copy of which is attached as Exhibit 5 to this Amendment. In the December 12th Press Release, Mr. Wilson set forth his views regarding the Issuer's failure to effectively manage a succession plan, and reiterated his belief in the need for the Issuer to add refreshed, experienced directors who can advise on the CEO selection process and hold management accountable to restore the value of the Issuer for shareholders. The information contained in Exhibit 5 of this Amendment is incorporated herein by reference. Mr. Wilson has attempted to constructively engage with the Issuer to arrive at a solution that Mr. Wilson believes puts the Issuer in the best position to unlock value for the benefit of all shareholders. However, notwithstanding Mr. Wilson being the Issuer's largest shareholder filing on Schedule 13D, and his obvious extensive experience with the Issuer and its industry, there are no assurances that Mr. Wilson's constructive attempts and suggestions to help the Issuer improve across all measurable quantitative and qualitive metrics will be acknowledged or acted upon by the board of directors of the Issuer. Mr. Wilson may continue to engage with the Issuer depending on the Issuer's openness to …The first part of Item 4 of the SCHEDULE 13D/A filed 2025-12-15; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-06 | Fmr LLC | 10.4% | SCHEDULE 13G/A |
| 2025-08-11 | Dennis J. Wilson | 8.4% | SCHEDULE 13D/A |
| 2025-10-07 | Fmr LLC | 3.6% | SCHEDULE 13G/A |
| 2025-10-08 | LIPO Investments (USA), Inc. | 8.4% | SCHEDULE 13D/A |
| 2025-11-13 | G1 Execution Services, LLC | 5.7% | SCHEDULE 13G |
| 2025-12-15 | LIPO Investments (USA), Inc. | 8.4% | SCHEDULE 13D/A |
| 2025-12-30 | Dennis J. Wilson | 8.4% | SCHEDULE 13D/A |
| 2026-02-27 | Dennis J. Wilson | 8.4% | SCHEDULE 13D/A |
| 2026-03-09 | Dennis J. Wilson | 8.4% | SCHEDULE 13D/A |
| 2026-03-16 | Dennis J. Wilson | 8.4% | SCHEDULE 13D/A |
| 2026-03-19 | Dennis J. Wilson | 8.4% | SCHEDULE 13D/A |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-03-30 | Dennis J. Wilson | 8.6% | SCHEDULE 13D/A |
| 2026-04-14 | Dennis J. Wilson | 8.6% | SCHEDULE 13D/A |
| 2026-04-28 | Vanguard Capital Management | 7.22% | SCHEDULE 13G |
| 2026-05-01 | Dennis J. Wilson | 8.6% | SCHEDULE 13D/A |
| 2026-05-08 | Dennis J. Wilson | 8.6% | SCHEDULE 13D/A |
| 2026-05-20 | Dennis J. Wilson | 8.7% | SCHEDULE 13D/A |
| 2026-05-28 | Dennis J. Wilson | 8.7% | SCHEDULE 13D/A |
| 2026-07-20 | Dennis J. Wilson | 8.6% | SCHEDULE 13D/A |
| 2026-08-03 | Dennis J. Wilson | 8.4% | SCHEDULE 13D/A |
| 2026-09-03 | Dennis J. Wilson | 8.6% | SCHEDULE 13D/A |
Tools for this story
Each opens in a new tab, filled in for lululemon athletica inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.